Microvascular invasion (MVI) is one of the most important factors for the recurrence of hepatocellular carcinoma (HCC), however, accurate preoperative evaluation of MVI is quietly difficult because of the controversy results caused by the conventional imaging features. Compared with diffusion-weighted imaging (DWI), Intravoxel incoherent motion (IVIM) diffusion-weighted MR imaging could better characterize heterogeneity and irregularity of tissue components, and thus may have the potential to better evaluate MVI. In this study, we prospectively determine the usefulness of IVIM parameters and conventional radiologic features for preoperative prediction of MVI in patients with HCC.
1. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A (2015) Global cancer statistics, 2012. CA Cancer J Clin 65:87-108.
2. Kudo M, Trevisani F, Abou-Alfa GK, Rimassa L (2016) Hepatocellular Carcinoma: Therapeutic Guidelines and Medical Treatment. Liver Cancer 6:16-26.
3. Forner A, Llovet JM, Bruix J (2012) Hepatocellular carcinoma. Lancet 379:1245-1255.
4. Hirokawa F, Hayashi M, Asakuma M, Shimizu T, Inoue Y, Uchiyama K (2016) Risk factors and patterns of early recurrence after curative hepatectomy for hepatocellular carcinoma. Surg Oncol 25:24-29.
5. Rodriguez-Peralvarez M, Luong TV, Andreana L, Meyer T, Dhillon AP, Burroughs AK (2013) A systematic review of microvascular invasion in hepatocellular carcinoma: diagnostic and prognostic variability. Ann Surg Oncol 20:325-339.
6. Witjes CD, Willemssen FE, Verheij J et al (2012) Histological differentiation grade and microvascular invasion of hepatocellular carcinoma predicted by dynamic contrast-enhanced MRI. J Magn Reson Imaging 36:641-647.
7. Pawlik TM, Gleisner AL, Anders RA, Assumpcao L, Maley W, Choti MA (2007) Preoperative assessment of hepatocellular carcinoma tumor grade using needle biopsy: implications for transplant eligibility. Ann Surg 245:435-442.
8. Ramos Rubio E, Llado Garriga L (2010) [Usefulness of pre-surgical biopsy in selecting patients with hepatocellular carcinoma for liver transplant]. Cir Esp 87:133-138.
9. Hirokawa F, Hayashi M, Miyamoto Y et al (2014) Outcomes and predictors of microvascular invasion of solitary hepatocellular carcinoma. Hepatol Res 44:846-853.
10. Renzulli M, Brocchi S, Cucchetti A et al (2016) Can Current Preoperative Imaging Be Used to Detect Microvascular Invasion of Hepatocellular Carcinoma? Radiology 279:432-442.
11. Jiang HY, Chen J, Xia CC, Cao LK, Duan T, Song B (2018) Noninvasive imaging of hepatocellular carcinoma: From diagnosis to prognosis. World J Gastroenterol 24:2348-2362.
12. Wei Y, Gao F, Wang M et al (2018) Intravoxel incoherent motion diffusion-weighted imaging for assessment of histologic grade of hepatocellular carcinoma: comparison of three methods for positioning region of interest. 10.1007/s00330-018-5638-1.
13. Xu P, Zeng M, Liu K, Shan Y, Xu C, Lin J (2014) Microvascular invasion in small hepatocellular carcinoma: is it predictable with preoperative diffusion-weighted imaging? J Gastroenterol Hepatol 29:330-336.
14. Valerio M, Zini C, Fierro D et al (2016) 3T multiparametric MRI of the prostate: Does intravoxel incoherent motion diffusion imaging have a role in the detection and stratification of prostate cancer in the peripheral zone? Eur J Radiol 85:790-794.
15. Marzi S, Piludu F, Sanguineti G et al (2017) The prediction of the treatment response of cervical nodes using intravoxel incoherent motion diffusion-weighted imaging. Eur J Radiol 92:93-102.
16. Iima M, Le Bihan D (2016) Clinical Intravoxel Incoherent Motion and Diffusion MR Imaging: Past, Present, and Future. Radiology 278(1):13-32.
17. Meeus EM, Zarinabad N, Manias KA et al (2018) Diffusion-weighted MRI and intravoxel incoherent motion model for diagnosis of pediatric solid abdominal tumors. J Magn Reson Imaging 47:1475-1486.
18. Nougaret S, Vargas HA, Lakhman Y et al (2016) Intravoxel Incoherent Motion-derived Histogram Metrics for Assessment of Response after Combined Chemotherapy and Radiation Therapy in Rectal Cancer: Initial Experience and Comparison between Single-Section and Volumetric Analyses. Radiology 280:446-454.
19. Suo S, Lin N, Wang H et al (2015) Intravoxel incoherent motion diffusion-weighted MR imaging of breast cancer at 3.0 tesla: Comparison of different curve-fitting methods. J Magn Reson Imaging 42:362-370.
20. Shen N, Zhao L, Jiang J et al (2016) Intravoxel incoherent motion diffusion-weighted imaging analysis of diffusion and microperfusion in grading gliomas and comparison with arterial spin labeling for evaluation of tumor perfusion. J Magn Reson Imaging 44:620-632.
21. Song XL, Kang HK, Jeong GW et al (2016) Intravoxel incoherent motion diffusion-weighted imaging for monitoring chemotherapeutic efficacy in gastric cancer. World J Gastroenterol 22:5520-5531.
22. Woo S, Lee JM, Yoon JH, Joo I, Han JK, Choi BI (2014) Intravoxel incoherent motion diffusion-weighted MR imaging of hepatocellular carcinoma: correlation with enhancement degree and histologic grade. Radiology 270:758-767.
23. Joo I, Lee JM, Han JK, Choi BI (2014) Intravoxel incoherent motion diffusion-weighted MR imaging for monitoring the therapeutic efficacy of the vascular disrupting agent CKD-516 in rabbit VX2 liver tumors. Radiology 272:417-426.
24. Lee Y, Lee SS, Kim N et al (2015) Intravoxel incoherent motion diffusion-weighted MR imaging of the liver: effect of triggering methods on regional variability and measurement repeatability of quantitative parameters. Radiology 274:405-415.
25. Amin MB, Edge SB, Greene FL, et al. AJCC cancer Staging Manual. 8th ed. New York: Springer;2017.
26. Jerjir N, Bruyneel L, Haspeslagh M, Quenet S, Coenegrachts K (2017) Intravoxel incoherent motion and dynamic contrast-enhanced MRI for differentiation between hepatocellular adenoma and focal nodular hyperplasia. Br J Radiol 90:20170007.
27. Choi IY, Lee SS, Sung YS et al (2017) Intravoxel incoherent motion diffusion-weighted imaging for characterizing focal hepatic lesions: Correlation with lesion enhancement. J Magn Reson Imaging 45:1589-1598.
28. Klauss M, Mayer P, Maier-Hein K et al (2016) IVIM-diffusion-MRI for the differentiation of solid benign and malign hypervascular liver lesions-Evaluation with two different MR scanners. Eur J Radiol 85:1289-1294.
29. Shirota N, Saito K, Sugimoto K, Takara K, Moriyasu F, Tokuuye K (2016) Intravoxel incoherent motion MRI as a biomarker of sorafenib treatment for advanced hepatocellular carcinoma: a pilot study. Cancer Imaging 16:1.
30. Wang WT, Yang L, Yang ZX et al (2018) Assessment of Microvascular Invasion of Hepatocellular Carcinoma with Diffusion Kurtosis Imaging. 286:571-580.
31. Matsui O, Kobayashi S, Sanada J et al (2011) Hepatocelluar nodules in liver cirrhosis: hemodynamic evaluation (angiography-assisted CT) with special reference to multi-step hepatocarcinogenesis. Abdom Imaging 36:264-272.
32. Chou CT, Chen RC, Lin WC, Ko CJ, Chen CB, Chen YL (2014) Prediction of microvascular invasion of hepatocellular carcinoma: preoperative CT and histopathologic correlation. AJR Am J Roentgenol 203:W253-259.